ArticleCurrent cancer drug targets2025

LMNB1/CDKN1A Signaling Regulates the Cell Cycle and Promotes Hepatocellular Carcinoma Progression.

Dute Gao et al.PubMed ↗Publisher ↗

No numbers read from the abstract.